Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioRestorative Therapies, Inc.BRTX · Entity 8277 | Director | February 14, 2025 | February 19, 2025 |
| NeuroPace IncNPCE · Entity 5459 | Chief Financial Officer | September 20, 2026 | September 21, 2026 |
| STAAR SURGICAL COSTAA · Entity 4851 | Chief Financial Officer | March 12, 2025 | March 14, 2025 |
| Sientra, Inc.SIEN · Entity 108294 | General Manager miraDry & SVP | August 06, 2018 | August 08, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioRestorative Therapies, Inc.
Report date February 14, 2025 · Filed February 19, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.46 · Expires 2035-02-14 | Direct | 52,632 |
Reported balance
After 2025-02-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-02-14 · Grant · Acquired 52,632 · Balance 52,632 F2: The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $5.08 · Expires 2031-11-04 | Direct | 10,490 |
Reported balance
Holding disclosure · report date 2025-02-14 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance 10,490 F1: The option is currently exercisable. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.91 · Expires 2033-02-17 | Direct | 32,028 |
Reported balance
Holding disclosure · report date 2025-02-14 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 32,028 F1: The option is currently exercisable. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.45 · Expires 2034-02-13 | Direct | 79,646 |
Reported balance
Holding disclosure · report date 2025-02-14 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 79,646 F1: The option is currently exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The option is currently exercisable.
F2: The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested.
NeuroPace Inc
Report date September 20, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,508 |
Reported balance
After 2026-09-20 transaction · row 1
1 source rowRow 1 · 2026-09-20 · Tax withholding · Disposed 1,162 · Balance 67,508 F1: Represents the number of shares withheld by the Issuer on September 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares withheld by the Issuer on September 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.
STAAR SURGICAL CO
Report date March 12, 2025 · Filed March 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,242 |
Reported balance
After 2025-03-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-03-12 · Exercise / conversion · Acquired 8,153 · Balance 56,242 F1: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,153 shares) on March 12, 2025, and will vest as 1/3 (8,153 shares) on March 12, 2026, and 1/3 (8,154 shares) on March 12, 2027. F2: Includes previously granted RSUs, which are subject to future vesting. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 16,307 |
Reported balance
After 2025-03-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-03-12 · Exercise / conversion · Disposed 8,153 · Balance 16,307 F3: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,153 shares) on March 12, 2025, and will vest as 1/3 (8,153 shares) on March 12, 2026, and 1/3 (8,154 shares) on March 12, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,153 shares) on March 12, 2025, and will vest as 1/3 (8,153 shares) on March 12, 2026, and 1/3 (8,154 shares) on March 12, 2027.
F2: Includes previously granted RSUs, which are subject to future vesting.
F3: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.
Sientra, Inc.
Report date August 06, 2018 · Filed August 08, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (RSUs)SEC Table I · non-derivative | Direct | 143,475 |
Reported balance
After 2018-08-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-08-06 · Grant · Acquired 80,000 · Balance 143,475 F1: The Restricted Stock Units (RSUs) vest upon the achievement of certain performance measures and in three equal annual installments beginning August 6, 2018. F2: Includes 6,067 shares of Common Stock purchased pursuant to the Issuer's Employee Stock Purchase Plan (ESPP). |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) vest upon the achievement of certain performance measures and in three equal annual installments beginning August 6, 2018.
F2: Includes 6,067 shares of Common Stock purchased pursuant to the Issuer's Employee Stock Purchase Plan (ESPP).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2026 Filed Sep 21, 2026 20:56 UTC | NeuroPace Inc NPCE · Entity 5459 | Tax withholdingCommon Stock | 1,162 | $14.28 | $16,593.36 |
DisclosureSEC source: 0001562229-26-000005 · wk-form4_1790024175.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,508 F1 · shares: Represents the number of shares withheld by the Issuer on September 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on September 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:51 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 44,800 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0001562229-26-000002 · form4-05192026_080535.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,800 Underlying: Common Stock · 44,800 shares Expires 2036-05-14 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:51 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 16,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001562229-26-000002 · form4-05192026_080535.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,670 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 20:32 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 87,950 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0001415889-25-018096 · form4-06242025_080651.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,950 Underlying: Common Stock · 87,950 shares Expires 2035-06-19 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on June 20, 2026. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 20:32 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantCommon Stock | 51,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-018096 · form4-06242025_080651.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,850 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on June 20, 2026 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 23:19 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 8,153 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039702 · ownership.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,307 Underlying: Common Stock · 8,153 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1 · derivative.exercise_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,153 shares) on March 12, 2025, and will vest as 1/3 (8,153 shares) on March 12, 2026, and 1/3 (8,154 shares) on March 12, 2027. F1 · derivative.expiration_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,153 shares) on March 12, 2025, and will vest as 1/3 (8,153 shares) on March 12, 2026, and 1/3 (8,154 shares) on March 12, 2027. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 23:19 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 8,153 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039702 · ownership.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,153 shares) on March 12, 2025, and will vest as 1/3 (8,153 shares) on March 12, 2026, and 1/3 (8,154 shares) on March 12, 2027. F2 · balance_after: Includes previously granted RSUs, which are subject to future vesting. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 00:40 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 4,061 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037553 · ownership.xml · derivative · entry 6 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,062 Underlying: Common Stock · 4,061 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU and RSU represents the right to receive one share of the Corporation's common stock upon vesting. F3 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 10, 2023. These RSUs vested as to 1/3 (4,061 shares) on March 10, 2024, 1/3 (4,061 shares) on March 10, 2025, and will vest as to the remaining 1/3 (4,062 shares) on March 10, 2026. F3 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 10, 2023. These RSUs vested as to 1/3 (4,061 shares) on March 10, 2024, 1/3 (4,061 shares) on March 10, 2025, and will vest as to the remaining 1/3 (4,062 shares) on March 10, 2026. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 00:40 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 4,061 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037553 · ownership.xml · nonDerivative · entry 3 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Reflects RSUs granted to the Reporting Person on March 10, 2023. These RSUs vested as to 1/3 (4,061 shares) on March 10, 2024, 1/3 (4,061 shares) on March 10, 2025, and will vest as to the remaining 1/3 (4,062 shares) on March 10, 2026. F4 · balance_after: Includes previously granted RSUs, which are subject to future vesting. Read SEC document |
| March 07, 2025 Filed Mar 12, 2025 00:40 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 3,075 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037553 · ownership.xml · derivative · entry 5 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,075 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU and RSU represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 7, 2022. These RSUs vested as to 1/3 (3,075 shares) on March 7, 2023, 1/3 (3,075 shares) on March 7, 2024, and 1/3 (3,075 shares) on March 7, 2025. F2 · derivative.expiration_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 7, 2022. These RSUs vested as to 1/3 (3,075 shares) on March 7, 2023, 1/3 (3,075 shares) on March 7, 2024, and 1/3 (3,075 shares) on March 7, 2025. Read SEC document |
| March 07, 2025 Filed Mar 12, 2025 00:40 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 2,614 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037553 · ownership.xml · derivative · entry 4 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,614 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU and RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1 · derivative.exercise_date: Reflects performance stock units (PSUs) granted to the Reporting Person on March 7, 2022, based on the Corporation's performance relative to pre-established financial metrics. These PSUs vested as to 1/3 (2,614 shares) on March 7, 2023, 1/3 (2,614 shares) on March 7, 2024, and 1/3 (2,614 shares) on March 7, 2025. F1 · derivative.expiration_date: Reflects performance stock units (PSUs) granted to the Reporting Person on March 7, 2022, based on the Corporation's performance relative to pre-established financial metrics. These PSUs vested as to 1/3 (2,614 shares) on March 7, 2023, 1/3 (2,614 shares) on March 7, 2024, and 1/3 (2,614 shares) on March 7, 2025. Read SEC document |
| March 07, 2025 Filed Mar 12, 2025 00:40 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 3,075 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037553 · ownership.xml · nonDerivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 7, 2022. These RSUs vested as to 1/3 (3,075 shares) on March 7, 2023, 1/3 (3,075 shares) on March 7, 2024, and 1/3 (3,075 shares) on March 7, 2025. Read SEC document |
| March 07, 2025 Filed Mar 12, 2025 00:40 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 2,614 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037553 · ownership.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects performance stock units (PSUs) granted to the Reporting Person on March 7, 2022, based on the Corporation's performance relative to pre-established financial metrics. These PSUs vested as to 1/3 (2,614 shares) on March 7, 2023, 1/3 (2,614 shares) on March 7, 2024, and 1/3 (2,614 shares) on March 7, 2025. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:31 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 52,632 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001021771-25-000044 · form4.xml · derivative · entry 4 Williams Patrick F. · CIK 0001562229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,632 Underlying: Common Stock · 52,632 shares Expires 2035-02-14 F2 · derivative.exercise_date: The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:14 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 21,908 | $0.00 Strike: $37.64 | $0.00 |
DisclosureSEC source: 0000950170-24-031662 · ownership.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,908 Underlying: Common Stock · 21,908 shares Expires 2034-03-11 F3 · derivative.exercise_date: Stock options granted to the Reporting Person on March 12, 2024. Options will vest and become exercisable as to 1/3 (7,302 shares) on March 12, 2025, with the remaining 2/3 (14,606 shares) vesting and becoming exercisable monthly over the following 24 months in equal amounts on a monthly basis. In the event such amount does not evenly divide into 24 months, the remaining balance of options will vest and become exercisable on March 12, 2027. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:14 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 24,460 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-031662 · ownership.xml · derivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,460 Underlying: Common Stock · 24,460 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (8,153 shares) on March 12, 2025, 1/3 (8,153 shares) on March 12, 2026, and 1/3 (8,154 shares) on March 12, 2027. F2 · derivative.expiration_date: RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (8,153 shares) on March 12, 2025, 1/3 (8,153 shares) on March 12, 2026, and 1/3 (8,154 shares) on March 12, 2027. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 10:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 2,614 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028906 · ownership.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects shares issued upon vesting of performance stock units (PSUs) granted on March 7, 2022, based on the Corporation's performance relative to pre-established financial metrics. These PSUs vested as to 1/3 (2,614 shares) on March 7, 2023, 1/3 (2,614 shares) on March 7, 2024, and will vest as to the remaining 1/3 (2,614 shares) on March 7, 2025. F2 · balance_after: Includes previously granted restricted stock units (RSUs), which are subject to future vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:25 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 79,646 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001021771-24-000054 · form4.xml · derivative · entry 3 Williams Patrick F. · CIK 0001562229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,646 Underlying: Common Stock · 79,646 shares Expires 2034-02-13 F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing every month thereafter until fully vested. Read SEC document |
| August 10, 2023 Filed Aug 11, 2023 22:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 2,539 | $44.10 | $111,969.90 |
DisclosureSEC source: 0001209191-23-045487 · doc4.xml · nonDerivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,861 Read SEC document |
| August 10, 2023 Filed Aug 11, 2023 22:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 5,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-045487 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:53 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 1,987 | $54.79 | $108,867.73 |
DisclosureSEC source: 0001209191-23-035131 · doc4.xml · nonDerivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,400 Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:53 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 5,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035131 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:35 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 22,281 | $0.00 Strike: $56.63 | $0.00 |
DisclosureSEC source: 0001209191-23-018056 · doc4.xml · derivative · entry 3 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,281 Underlying: Common Stock · 22,281 shares Expires 2033-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/10/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/10/2026. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:35 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 12,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018056 · doc4.xml · nonDerivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Award of 12184 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/10/2024, 1/3 of the RSUs on 3/10/2025, and the remaining 1/3 of the RSUs on 3/10/2026. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:35 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 289 | $56.63 | $16,366.07 |
DisclosureSEC source: 0001209191-23-018056 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,492 Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 01:18 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 1,711 | $58.13 | $99,460.43 |
DisclosureSEC source: 0001209191-23-017423 · doc4.xml · nonDerivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Stock Units (PSUs) converted into common shares on a one-to-one basis, with the amount representing the vesting of PSUs awarded on March 7, 2022, with achievement based on the Corporation's satisfaction of pre-established financial metrics. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 01:18 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 1,063 | $58.13 | $61,792.19 |
DisclosureSEC source: 0001209191-23-017423 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,781 Read SEC document |
| February 17, 2023 Filed Feb 17, 2023 22:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 32,028 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0001567619-23-003332 · doc1.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,028 Underlying: Common Stock · 32,028 shares Expires 2033-02-17 F2 · derivative.exercise_date: The option vests and becomes exercisable in twelve monthly installments of 2,669 shares beginning on March 17, 2023 and continuing every month thereafter until fully vested. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 20:19 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 10,490 | $0.00 Strike: $5.08 | $0.00 |
DisclosureSEC source: 0001567619-22-019191 · doc1.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,490 Underlying: Common Stock · 10,490 shares Expires 2031-11-04 F2 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with a reduced exercise price. F1 · derivative.exercise_date: The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 20:19 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 10,490 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0001567619-22-019191 · doc1.xml · derivative · entry 1 Williams Patrick F. · CIK 0001562229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,490 shares Expires 2031-11-04 F2 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with a reduced exercise price. F1 · derivative.exercise_date: The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:46 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 5,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035145 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 23:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 19,188 | $0.00 Strike: $74.80 | $0.00 |
DisclosureSEC source: 0001209191-22-017271 · doc4.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,188 Underlying: Common Stock · 19,188 shares Expires 2032-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/7/2023 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/7/2025. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 23:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 9,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017271 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Award of 9225 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/7/23, 1/3 of the RSUs on 3/7/24, and the remaining 1/3 of the RSUs on 3/7/25. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 22:38 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 10,490 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0001567619-21-019503 · doc1.xml · derivative · entry 1 Williams Patrick F. · CIK 0001562229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,490 Underlying: Common Stock · 10,490 shares Expires 2031-11-04 F1 · derivative.exercise_date: The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 5,121 | $139.38 | $713,764.98 |
DisclosureSEC source: 0001209191-21-056607 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,619 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.53 to $142.28, inclusive. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 20:22 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 2,500 | $140.58 | $351,450.00 |
DisclosureSEC source: 0001209191-21-051097 · doc4.xml · nonDerivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,740 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.41 to $142.16, inclusive. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:22 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 5,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051097 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:18 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 5,312 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020524 · doc4.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,312 Underlying: Common Stock · 5,312 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:18 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 2,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020524 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Award of 2513 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/12/22, 1/3 of the RSUs on 3/12/23, and the remaining 1/3 of the RSUs on 3/12/24. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:28 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 30,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-046450 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,727 F1 · balance_after: Award of 30,727 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights. Regarding half of the RSUs, 15,363, 1/3 of the shares (5121) will vest on 8/10/21, 1/3 of the shares (5121) will vest on 8/10/22, and 1/3 of the shares (5121) will vest on 8/10/23. Regarding the other half of the RSUs, 15,364, they may vest based on achievement of pre-established, quantitative corporate financial performance metrics. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 21:25 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock (RSUs) | 80,000 | $20.97 | $1,677,600.00 |
DisclosureSEC source: 0001209191-18-045946 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · General Manager miraDry & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,475 F1 · shares: The Restricted Stock Units (RSUs) vest upon the achievement of certain performance measures and in three equal annual installments beginning August 6, 2018. F2 · balance_after: Includes 6,067 shares of Common Stock purchased pursuant to the Issuer's Employee Stock Purchase Plan (ESPP). Read SEC document |
| May 07, 2018 Filed May 9, 2018 17:20 UTC | Sientra, Inc. SIEN · Entity 108294 | PurchaseCommon Stock | 7,408 | $13.50 | $100,008.00 |
DisclosureSEC source: 0001209191-18-028936 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,408 Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 18:55 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock (RSUs) | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-004991 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · shares: The Restricted Stock Units (RSUs) vest in equal 1/3 amounts over a three (3) year period commencing on January 19, 2019. Vesting is subject to Reporting Person's continuous service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.